You have full text access to this OnlineOpen article

The acute phase protein serum amyloid A primes neutrophils

  1. Elaine Hatanaka,
  2. Fernanda Pereira Ribeiro,
  3. Ana Campa*

Article first published online: 9 JAN 2006

DOI: 10.1016/S0928-8244(03)00112-3

Issue

FEMS Immunology & Medical Microbiology

FEMS Immunology & Medical Microbiology

Volume 38, Issue 1, pages 81–84, August 2003

Additional Information

How to Cite

Hatanaka, E., Pereira Ribeiro, F. and Campa, A. (2003), The acute phase protein serum amyloid A primes neutrophils. FEMS Immunology & Medical Microbiology, 38: 81–84. doi: 10.1016/S0928-8244(03)00112-3

Author Information

  1. Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, CEP 05508–900, SP, Brazil

* *Corresponding author. Tel.: +55 (11) 3091-3637; Fax: +55 (11) 3813–2197, E-mail address: anacampa@usp.br

Publication History

  1. Issue published online: 9 JAN 2006
  2. Article first published online: 9 JAN 2006
  3. Received 20 January 2003, Revised 21 March 2003, Accepted 25 March 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (203K)

References

  • [1]
    Baumann, H., Gauldie, J. (1994) The acute phase response. Immunol. Today 15, 74–80.
  • [2]
    Godenir, N.L., Jeenah, M.S., Coetzee, G.A., van der Westhuyzen, D.R., Strachan, A.F., De Beer, F.C. (1985) Standardization of quantification of serum amyloid A protein (SAA) in human serum. J. Immunol. Methods 83, 217–225.
  • [3]
    Urieli-Shoval, S., Linke, R.P., Matzner, Y. (2000) Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7, 64–69.
  • [4]
    Uhlar, C.M., Whitehead, A.S. (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265, 501–523.
    Direct Link:
  • [5]
    Suffredini, A.F., Fantuzzi, G., Badolato, R., Oppenheim, J.J., O'Grady, N.P. (1999) New insights into the biology of the acute phase response. J. Clin. Immunol. 19, 203–214.
  • [6]
    Hampton, M.B., Kettle, A.J., Winterbourn, C.C. (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92, 3007–3017.
  • [7]
    Smith, J.A. (1994) Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukoc. Biol. 56, 672–686.
  • [8]
    Furlaneto, C.J., Campa, A. (2000) A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-α, interleukin-1β, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 268, 405–408.
  • [9]
    Koenderman, L., Yazdanbakhsh, M., Roos, D., Verhoeven, J.A. (1989) Dual mechanism in priming of the chemoattractant-induced respiratory burst in human granulocytes. J. Immunol. 142, 623–628.
  • [10]
    Dularay, B., Elson, C.J., Clements-Jewery, S., Damais, C., Lando, D. (1990) Recombinant human interleukin-1 beta primes human polymorphonuclear leukocytes for stimulus-induced myeloperoxidase release. J. Leukoc. Biol. 47, 158–163.
  • [11]
    Shalaby, M.R. M.A. Palladino 3rd Hirabayashi, S.E., Eessalu, T.E., Lewis, G.D., Shepard, H.M., Aggarwal, B.B. (1987) Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J. Leukoc. Biol. 41, 196–204.
  • [12]
    Vercellotti, G.M., Yin, H.Q., Gustafson, K.S., Nelson, R.D., Jacob, H.S. (1988) Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 71, 1100–1107.
  • [13]
    Liu, J.H. and Djeu, J.Y. (1995) Role of cytokines in neutrophil functions. In: Human Cytokines: Their Role in Disease and Therapy (Aggarwal, B.B. and Puri, R.K., Eds.), pp. 71–86. Blackwell Science, Cambridge.
  • [14]
    Kushner, I. (1982) The phenomenon of the acute phase response. Ann. NY Acad. Sci. 389, 39–48.
    Direct Link:
  • [15]
    Badolato, R., Wang, J.M., Stornello, S.L., Ponzi, A.N., Duse, M., Musso, T. (2000) Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity. J. Leukoc. Biol. 67, 381–386.
  • [16]
    Yamada, T., Wada, A., Itoh, K., Igari, J. (2000) Serum amyloid A secretion from monocytic leukaemia cell line THP-1 and cultured human peripheral monocytes. Scand. J. Immunol. 52, 7–12.
    Direct Link:
  • [17]
    Yavin, E.J., Preciado-Patt, L., Rosen, O., Yaron, M., Suessmuth, R.D., Levartowsky, D., Jung, G., Lider, O., Fridkin, M. (2000) Serum amyloid A-derived peptides, present in human rheumatic synovial fluids, induce the secretion of interferon-gamma by human CD(4)(+) T-lymphocytes. FEBS Lett. 28, 259–262.
  • [18]
    Badolato, R., Wang, J.M., Murphy, W.J., Lloyd, A.R., Michiel, D.F., Bausserman, L.L., Kelvin, D.J., Oppenheim, J.J. (1994) Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180, 203–209.
  • [19]
    Steel, D., Whitehead, A.S. (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15, 81–88.
View Full Article (HTML) Get PDF (203K)